| Literature DB >> 29553558 |
Wyatt E Lanik1, Lily Xu2, Cliff J Luke1, Elise Z Hu2, Pranjal Agrawal2, Victoria S Liu2, Rajesh Kumar1, Alexa M Bolock1, Congrong Ma3, Misty Good4.
Abstract
Human small intestinal enteroids are derived from the crypts and when grown in a stem cell niche contain all of the epithelial cell types. The ability to establish human enteroid ex vivo culture systems are important to model intestinal pathophysiology and to study the particular cellular responses involved. In recent years, enteroids from mice and humans are being cultured, passaged, and banked away for future use in several laboratories across the world. This enteroid platform can be used to test the effects of various treatments and drugs and what effects are exerted on different cell types in the intestine. Here, a protocol for establishing primary stem cell-derived small intestinal enteroids derived from neonatal mice and premature human intestine is provided. Moreover, this enteroid culture system was utilized to test the effects of species-specific breast milk. Mouse breast milk can be obtained efficiently using a modified human breast pump and expressed mouse milk can then be used for further research experiments. We now demonstrate the effects of expressed mouse, human, and donor breast milk on the growth and proliferation of enteroids derived from neonatal mice or premature human small intestine.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29553558 PMCID: PMC5912412 DOI: 10.3791/56921
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355